0 XP   0   0   0

Rhythm Pharmaceuticals Inc
Buy, Hold or Sell?

I guess you are interested in Rhythm Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Rhythm Pharmaceuticals Inc

Let's start. I'm going to help you getting a better view of Rhythm Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Rhythm Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Rhythm Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Rhythm Pharmaceuticals Inc. The closing price on 2022-09-30 was $24.50 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Rhythm Pharmaceuticals Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Rhythm Pharmaceuticals Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Rhythm Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Rhythm Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -2,448.2% means that $-24.48 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is -496.4%. The company is making a huge loss. -2
  • The TTM is -2,448.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-496.4%TTM-2,448.2%+1,951.9%
TTM-2,448.2%YOY28,021.1%-30,469.3%
TTM-2,448.2%5Y5,114.6%-7,562.8%
5Y5,114.6%10Y3,527.3%+1,587.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-496.4%-242.4%-254.0%
TTM-2,448.2%-275.9%-2,172.3%
YOY28,021.1%-342.1%+28,363.2%
5Y5,114.6%-475.7%+5,590.3%
10Y3,527.3%-561.7%+4,089.0%
1.1.2. Return on Assets

Shows how efficient Rhythm Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rhythm Pharmaceuticals Inc to the Biotechnology industry mean.
  • -14.4% Return on Assets means that Rhythm Pharmaceuticals Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is -16.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.2%TTM-14.4%-1.8%
TTM-14.4%YOY-8.3%-6.1%
TTM-14.4%5Y-12.4%-2.0%
5Y-12.4%10Y-129.3%+116.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.2%-9.7%-6.5%
TTM-14.4%-8.7%-5.7%
YOY-8.3%-9.2%+0.9%
5Y-12.4%-11.5%-0.9%
10Y-129.3%-12.4%-116.9%
1.1.3. Return on Equity

Shows how efficient Rhythm Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rhythm Pharmaceuticals Inc to the Biotechnology industry mean.
  • -23.0% Return on Equity means the company generated $-0.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is -23.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.0%TTM-17.8%-5.2%
TTM-17.8%YOY-9.2%-8.7%
TTM-17.8%5Y-12.5%-5.4%
5Y-12.5%10Y-16.0%+3.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.0%-11.8%-11.2%
TTM-17.8%-11.1%-6.7%
YOY-9.2%-10.6%+1.4%
5Y-12.5%-13.5%+1.0%
10Y-16.0%-14.5%-1.5%

1.2. Operating Efficiency of Rhythm Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Rhythm Pharmaceuticals Inc is operating .

  • Measures how much profit Rhythm Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rhythm Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of -495.3% means the company generated $-4.95  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is -495.3%. The company is operating very inefficient. -2
  • The TTM is -2,665.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-495.3%TTM-2,665.5%+2,170.2%
TTM-2,665.5%YOY43,281.4%-45,946.9%
TTM-2,665.5%5Y8,123.2%-10,788.7%
5Y8,123.2%10Y5,602.2%+2,521.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-495.3%-232.1%-263.2%
TTM-2,665.5%-269.6%-2,395.9%
YOY43,281.4%-309.3%+43,590.7%
5Y8,123.2%-466.7%+8,589.9%
10Y5,602.2%-572.5%+6,174.7%
1.2.2. Operating Ratio

Measures how efficient Rhythm Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 597.4% means that the operating costs are $5.97for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is 5.974. The company is inefficient in keeping operating costs low. -1
  • The TTM is 28.811. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.974TTM28.811-22.837
TTM28.811YOY283.091-254.279
TTM28.8115Y62.380-33.569
5Y62.38010Y43.021+19.359
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9743.321+2.653
TTM28.8113.542+25.269
YOY283.0913.491+279.600
5Y62.3805.744+56.636
10Y43.0217.007+36.014

1.3. Liquidity of Rhythm Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Rhythm Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 559.4% means the company has $5.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is 5.594. The company is very able to pay all its short-term debts. +2
  • The TTM is 133.537. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.594TTM133.537-127.943
TTM133.537YOY17.369+116.168
TTM133.5375Y41.385+92.152
5Y41.38510Y29.705+11.680
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5945.266+0.328
TTM133.5376.060+127.477
YOY17.3696.366+11.003
5Y41.3856.692+34.693
10Y29.7056.457+23.248
1.3.2. Quick Ratio

Measures if Rhythm Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 807.0% means the company can pay off $8.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is 8.070. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 229.428. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.070TTM229.428-221.357
TTM229.428YOY28.965+200.463
TTM229.4285Y66.982+162.445
5Y66.98210Y46.584+20.399
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0704.055+4.015
TTM229.4284.865+224.563
YOY28.9655.192+23.773
5Y66.9825.275+61.707
10Y46.5844.997+41.587

1.4. Solvency of Rhythm Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Rhythm Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.30 means that Rhythm Pharmaceuticals Inc assets are financed with 29.5% credit (debt) and the remaining percentage (100% - 29.5%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is 0.295. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.175. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.295TTM0.175+0.121
TTM0.175YOY0.097+0.078
TTM0.1755Y0.103+0.072
5Y0.10310Y0.593-0.490
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2950.271+0.024
TTM0.1750.269-0.094
YOY0.0970.296-0.199
5Y0.1030.361-0.258
10Y0.5930.399+0.194
1.4.2. Debt to Equity Ratio

Measures if Rhythm Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 41.9% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is 0.419. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.223. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.419TTM0.223+0.197
TTM0.223YOY0.108+0.115
TTM0.2235Y0.110+0.112
5Y0.11010Y0.615-0.504
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4190.310+0.109
TTM0.2230.311-0.088
YOY0.1080.310-0.202
5Y0.1100.382-0.272
10Y0.6150.438+0.177

2. Market Valuation of Rhythm Pharmaceuticals Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Rhythm Pharmaceuticals Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -1.19 means the investor is paying $-1.19 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Rhythm Pharmaceuticals Inc:

  • The EOD is -7.015. Company is losing money. -2
  • The MRQ is -1.188. Company is losing money. -2
  • The TTM is -5.541. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-7.015MRQ-1.188-5.826
MRQ-1.188TTM-5.541+4.352
TTM-5.541YOY-11.754+6.213
TTM-5.5415Y-9.251+3.710
5Y-9.25110Y-6.380-2.871
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.015-2.115-4.900
MRQ-1.188-2.332+1.144
TTM-5.541-3.889-1.652
YOY-11.754-5.087-6.667
5Y-9.251-3.697-5.554
10Y-6.380-3.390-2.990
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Rhythm Pharmaceuticals Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Rhythm Pharmaceuticals Inc:

  • The MRQ is -0.008. Very Bad. -2
  • The TTM is 0.069. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.008TTM0.069-0.077
TTM0.069YOY0.314-0.245
TTM0.0695Y0.398-0.328
5Y0.39810Y0.3980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0080.003-0.011
TTM0.0690.019+0.050
YOY0.3140.042+0.272
5Y0.3980.020+0.378
10Y0.3980.017+0.381

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Rhythm Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.07 means the investor is paying $1.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Rhythm Pharmaceuticals Inc:

  • The EOD is 6.312. Seems overpriced? -1
  • The MRQ is 1.069. Good. +1
  • The TTM is 1.833. Good. +1
Trends
Current periodCompared to+/- 
EOD6.312MRQ1.069+5.243
MRQ1.069TTM1.833-0.763
TTM1.833YOY4.564-2.731
TTM1.8335Y3.467-1.635
5Y3.46710Y2.391+1.076
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.3121.843+4.469
MRQ1.0691.961-0.892
TTM1.8332.789-0.956
YOY4.5643.538+1.026
5Y3.4672.782+0.685
10Y2.3912.419-0.028

2.4. Latest News of Rhythm Pharmaceuticals Inc

Does Rhythm Pharmaceuticals Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Rhythm Pharmaceuticals Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-23
14:00
Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS)Read
2022-09-19
13:44
Rhythm Pharmaceuticals, Inc.'s (NASDAQ:RYTM) large institutional owners must be happy as stock continues to impress, up 4.0% over the past weekRead
2022-09-15
04:20
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public OfferingRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Rhythm Pharmaceuticals Inc.

3.1. Institutions holding Rhythm Pharmaceuticals Inc

Institutions are holding 93.8% of the shares of Rhythm Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31PRIMECAP Management Company12.40520.05476291991350000.5594
2022-03-31Federated Hermes Inc9.98630.13185065113226177880.6817
2022-03-31NEA Management Company, LLC9.6851.6346491230600
2022-03-31RA Capital Management, LLC9.60371.2244487106700
2022-06-30Baker Bros Advisors LP8.13290.0971412506200
2022-03-31Goldman Sachs Group Inc6.58460.008133397502432027.854
2022-03-31HHG PLC5.81820.01642951002-182933-5.8372
2022-03-31Vanguard Group Inc4.44990.00062257020-66501-2.8621
2022-03-31Franklin Resources Inc3.50830.0082177945424258215.7841
2022-06-30Alkeon Capital Management, LLC2.95740.0168150000015000000
2022-03-31Rock Springs Capital Management LP2.43890.3587123702660984697.2362
2022-06-30Mpm Asset Management, LLC1.79271.592190925800
2022-03-31State Street Corporation1.59930.0005811183-1119907-57.9935
2022-06-30Assenagon Asset Management SA1.35980.0106689720-16200-2.2949
2022-03-31FMR Inc1.0920.000555386775471.3814
2022-03-31Northern Trust Corp0.82190.0008416887-12184-2.8396
2022-06-30Geode Capital Management, LLC0.78820.0002399794-341095-46.0386
2022-03-31Millennium Management LLC0.71090.00223605924688814.9466
2022-06-30Samsara BioCapital, LLC0.68080.38234529300
2022-03-31Charles Schwab Investment Management Inc0.58820.00129832592193.1888
Total 85.00425.541343114710  

3.2. Funds holding Rhythm Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30PRIMECAP Odyssey Aggressive Growth9.45060.27784793393-9387-0.1954
2022-06-30Federated Hermes Kaufmann R7.09770.29523600000-19994-0.5523
2022-06-30Federated Hermes Kaufmann Growth7.09770.29393600000-19994-0.5523
2022-07-31Franklin Small Cap Value A3.61010.5587183107160407249.2317
2022-07-31Vanguard Total Stock Mkt Idx Inv2.9810.0016151195800
2022-06-30PRIMECAP Odyssey Growth2.61910.07771328446725465.7764
2022-06-30Franklin US Small Cap Value Equity2.41910.1331122699900
2022-06-30Janus Henderson Global Life Sciences D1.47630.0754748776-210741-21.9632
2022-06-30Janus Henderson Global Life Sciences1.47630.0756748776-210741-21.9632
2022-06-30Federated Hermes Kaufmann Small Cap A1.38010.0602700000-650000-48.1481
2022-06-30Federated Hermes Kaufmann Small Cap Grow1.38010.0601700000-650000-48.1481
2022-06-30Janus Henderson Glb Life Scn I2 USD1.31780.0746668382-158160-19.1351
2022-06-30Janus Global Life Science A USD1.31490.0744666917-238571-26.3472
2022-06-30Fidelity® Select Biotechnology1.09110.047355341100
2022-07-31Vanguard Extended Market Index Investor1.04820.00775316644580.0862
2022-07-31Franklin Small Cap Value VIP 10.94020.557647688214819045.0848
2022-04-30MEDICAL BioHealth EUR Acc0.8070.42740931300
2022-06-30APO Medical Opportunities R0.78450.1893397881253059174.738
2022-07-29iShares Biotechnology ETF0.66710.0532338341-524-0.1546
2022-05-31Fidelity® Small Cap Index0.60910.005730895700
Total 49.5683.346125141167  

3.3. Insider Transactions

Insiders are holding 0.343% of the shares of Rhythm Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-19Pamela J CramerSELL1349324.832224
2022-07-27Pamela J CramerSELL90111.682224
2022-07-01Hunter C SmithSELL75474.0857614
2022-03-29William T RobertsSELL102311.13
2022-02-15Hunter C SmithSELL8336.1
2022-02-15Joseph ShulmanSELL5576.1
2022-02-15Yann MazabraudSELL9346.1
2021-03-30David P MeekerBUY1000020.17111335
2020-12-02Ra Capital Management, L.P.SELL3093932.39
2020-08-31Nithya DesikanSELL2500030 
2020-07-01Ra Capital Management, L.P.SELL2552721.87
2020-06-29Ra Capital Management, L.P.SELL5204922.19
2020-06-26Todd FoleySELL30025.04
2020-06-25Ra Capital Management, L.P.SELL1156825.05
2020-06-24Todd FoleySELL9738825.34
2020-06-05Todd FoleySELL189620
2020-06-03Todd FoleySELL1824520.27
2020-06-01Todd FoleySELL1053520.08
2020-05-28Todd FoleySELL1915220.19
2020-05-26Todd FoleySELL4442120.47

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Rhythm Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--3.8825.158-25%5.772-33%5.699-32%4.103-5%
Book Value Per Share Growth---0.803-0.781-3%0.471-270%0.125-740%0.162-597%
Current Ratio--5.594133.537-96%17.369-68%41.385-86%29.705-81%
Debt To Asset Ratio--0.2950.175+69%0.097+205%0.103+188%0.593-50%
Debt To Equity Ratio--0.4190.223+88%0.108+290%0.110+280%0.615-32%
Dividend Per Share----0%-0%-0%-0%
Eps---0.893-0.873-2%-0.340-62%-0.705-21%-0.533-40%
Eps Growth--157.17246.894+235%-41.877+127%26.030+504%26.030+504%
Gains Per Share---0.803-0.781-3%0.471-270%0.125-740%0.162-597%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.897+12%
Net Profit Margin---4.964-24.482+393%280.211-102%51.146-110%35.273-114%
Operating Margin---4.953-26.655+438%432.814-101%81.232-106%56.022-109%
Operating Ratio--5.97428.811-79%283.091-98%62.380-90%43.021-86%
Pb Ratio6.312+83%1.0691.833-42%4.564-77%3.467-69%2.391-55%
Pe Ratio-7.015-490%-1.188-5.541+366%-11.754+889%-9.251+679%-6.380+437%
Peg Ratio---0.0080.069-111%0.314-102%0.398-102%0.398-102%
Price Per Share24.500+83%4.1509.678-57%23.063-82%19.936-79%13.749-70%
Quick Ratio--8.070229.428-96%28.965-72%66.982-88%46.584-83%
Return On Assets---0.162-0.144-11%-0.083-49%-0.124-23%-1.293+698%
Return On Equity---0.230-0.178-22%-0.092-60%-0.125-46%-0.160-30%
 EOD+1 -2MRQTTM+7 -11YOY+5 -135Y+5 -1310Y+9 -10

4.2. Fundamental Score

Let's check the fundamental score of Rhythm Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.015
Price to Book Ratio (EOD)Between0-16.312
Net Profit Margin (MRQ)Greater than0-4.964
Operating Margin (MRQ)Greater than0-4.953
Quick Ratio (MRQ)Greater than18.070
Current Ratio (MRQ)Greater than15.594
Debt to Asset Ratio (MRQ)Less than10.295
Debt to Equity Ratio (MRQ)Less than10.419
Return on Equity (MRQ)Greater than0.15-0.230
Return on Assets (MRQ)Greater than0.05-0.162
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Rhythm Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.465
Ma 20Greater thanMa 5023.988
Ma 50Greater thanMa 10021.609
Ma 100Greater thanMa 20013.242
OpenGreater thanClose23.660
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets277,675
Total Liabilities82,047
Total Stockholder Equity195,628
 As reported
Total Liabilities 82,047
Total Stockholder Equity+ 195,628
Total Assets = 277,675

Assets

Total Assets277,675
Total Current Assets249,332
Long-term Assets249,332
Total Current Assets
Cash And Cash Equivalents 113,207
Short-term Investments 122,389
Net Receivables 1,707
Other Current Assets 12,029
Total Current Assets  (as reported)249,332
Total Current Assets  (calculated)249,332
+/-0
Long-term Assets
Property Plant Equipment 3,918
Long Term Investments 15,786
Intangible Assets 8,311
Other Assets 16,114
Long-term Assets  (as reported)28,343
Long-term Assets  (calculated)44,129
+/- 15,786

Liabilities & Shareholders' Equity

Total Current Liabilities44,570
Long-term Liabilities37,477
Total Stockholder Equity195,628
Total Current Liabilities
Short-term Debt 644
Accounts payable 6,012
Other Current Liabilities 35,605
Total Current Liabilities  (as reported)44,570
Total Current Liabilities  (calculated)42,261
+/- 2,309
Long-term Liabilities
Long term Debt Total 35,863
Capital Lease Obligations Min Short Term Debt1,614
Long-term Liabilities Other 1,614
Long-term Liabilities  (as reported)37,477
Long-term Liabilities  (calculated)39,091
+/- 1,614
Total Stockholder Equity
Common Stock50
Retained Earnings -626,704
Accumulated Other Comprehensive Income -906
Capital Surplus 823,188
Total Stockholder Equity (as reported)195,628
Total Stockholder Equity (calculated)195,628
+/-0
Other
Capital Stock50
Cash and Short Term Investments 235,596
Common Stock Shares Outstanding 50,398
Common Stock Total Equity50
Current Deferred Revenue2,309
Liabilities and Stockholders Equity 277,675
Net Debt -110,949
Net Invested Capital 195,628
Net Tangible Assets 187,317
Net Working Capital 204,762
Short Long Term Debt Total 2,258



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302015-12-312014-12-312014-06-302013-12-312012-12-31
> Total Assets 
18,922
18,186
10,687
194
37,275
0
12,339
26,033
40,879
34,804
151,736
139,443
291,749
277,728
260,210
236,502
210,888
177,533
308,523
273,756
243,485
215,477
187,073
422,209
388,390
355,823
329,523
284,824
277,675
277,675284,824329,523355,823388,390422,209187,073215,477243,485273,756308,523177,533210,888236,502260,210277,728291,749139,443151,73634,80440,87926,03312,339037,27519410,68718,18618,922
   > Total Current Assets 
0
18,139
10,649
194
35,492
0
11,175
24,841
38,937
32,036
150,671
138,414
290,771
276,538
258,689
230,169
203,501
170,877
302,404
267,860
237,819
209,914
181,668
412,134
378,454
335,636
308,387
253,449
249,332
249,332253,449308,387335,636378,454412,134181,668209,914237,819267,860302,404170,877203,501230,169258,689276,538290,771138,414150,67132,03638,93724,84111,175035,49219410,64918,1390
       Cash And Cash Equivalents 
11,766
7,364
8,864
152
34,869
0
6,540
11,882
29,198
27,914
34,236
43,167
210,484
58,247
49,542
42,020
63,118
71,680
62,294
55,776
59,091
67,670
100,854
87,271
69,339
92,372
59,248
78,537
113,207
113,20778,53759,24892,37269,33987,271100,85467,67059,09155,77662,29471,68063,11842,02049,54258,247210,48443,16734,23627,91429,19811,8826,540034,8691528,8647,36411,766
       Short-term Investments 
5,270
10,398
469
0
0
0
3,997
12,002
9,017
2,501
113,846
93,286
77,070
214,139
202,519
179,503
132,049
90,755
230,165
201,648
169,535
134,114
71,938
317,479
298,815
235,982
235,607
162,427
122,389
122,389162,427235,607235,982298,815317,47971,938134,114169,535201,648230,16590,755132,049179,503202,519214,13977,07093,286113,8462,5019,01712,0023,99700046910,3985,270
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,025
862
1,707
1,7078621,02500000000000000000000000000
   > Long-term Assets 
0
47
38
0
0
0
1,164
0
1,942
2,768
1,065
1,029
978
1,190
1,521
6,333
7,387
6,656
6,119
5,896
5,666
5,563
5,405
10,075
9,936
20,187
21,136
31,375
28,343
28,34331,37521,13620,1879,93610,0755,4055,5635,6665,8966,1196,6567,3876,3331,5211,1909781,0291,0652,7681,94201,16400038470
       Property Plant Equipment 
44
24
15
0
17
0
930
876
822
845
840
779
728
939
1,120
5,931
6,986
5,959
5,716
5,493
5,263
5,160
5,002
4,747
4,722
4,554
4,335
4,164
3,918
3,9184,1644,3354,5544,7224,7475,0025,1605,2635,4935,7165,9596,9865,9311,1209397287798408458228769300170152444
       Long Term Investments 
0
0
0
0
60
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,533
11,815
18,356
15,786
15,78618,35611,81510,53300000000000000000000600000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
4,658
8,527
8,311
8,3118,5274,65855500000000000000000000000
       Long-term Assets Other 
0
23
23
0
0
0
234
0
1,120
1,923
225
250
250
251
401
402
401
697
403
403
403
403
403
328
328
15,633
12,143
27,211
16,114
16,11427,21112,14315,6333283284034034034034036974014024012512502502251,9231,120023400023230
> Total Liabilities 
2,502
75,646
75,025
552
5,274
0
5,042
4,458
5,113
5,710
6,948
5,785
7,432
8,091
13,954
16,013
29,421
28,418
27,503
20,655
17,732
18,540
20,545
41,262
36,701
33,560
45,372
49,055
82,047
82,04749,05545,37233,56036,70141,26220,54518,54017,73220,65527,50328,41829,42116,01313,9548,0917,4325,7856,9485,7105,1134,4585,04205,27455275,02575,6462,502
   > Total Current Liabilities 
2,502
3,060
2,439
552
5,274
0
4,731
4,167
4,843
5,460
6,720
5,579
7,247
7,803
13,582
12,567
26,090
25,207
24,417
17,696
14,904
15,848
17,994
16,850
17,459
23,467
606
47,274
44,570
44,57047,27460623,46717,45916,85017,99415,84814,90417,69624,41725,20726,09012,56713,5827,8037,2475,5796,7205,4604,8434,1674,73105,2745522,4393,0602,502
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
202
0
0
0
0
0
0
535
553
570
588
606
625
644
644625606588570553535000000202000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
202
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000202000000000000000
       Accounts payable 
2,245
1,465
523
535
1,428
0
1,895
1,491
1,293
5,379
6,637
5,494
7,161
7,803
13,582
3,992
6,565
7,745
10,415
5,932
4,761
15,329
4,900
9,147
5,009
4,614
5,737
12,010
6,012
6,01212,0105,7374,6145,0099,1474,90015,3294,7615,93210,4157,7456,5653,99213,5827,8037,1615,4946,6375,3791,2931,4911,89501,4285355231,4652,245
       Other Current Liabilities 
257
1,595
1,916
17
3,846
0
2,836
78
3,550
81
83
85
86
7,595
0
1,052
242
112
377
147
160
12,055
12,559
7,150
11,880
18,265
-5,737
25,199
35,605
35,60525,199-5,73718,26511,8807,15012,55912,0551601473771122421,05207,595868583813,550782,83603,846171,9161,595257
   > Long-term Liabilities 
0
72,586
72,586
0
0
0
311
0
270
250
228
206
185
288
372
3,446
3,331
3,211
3,086
2,959
2,828
2,692
2,551
24,412
19,242
10,093
1,945
1,781
37,477
37,4771,7811,94510,09319,24224,4122,5512,6922,8282,9593,0863,2113,3313,446372288185206228250270031100072,58672,5860
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,446
0
0
0
0
0
0
0
0
0
0
0
0
35,863
35,8630000000000003,446000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
80,950
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000080,950000000000
       Other Liabilities 
0
0
0
0
0
0
311
291
680
250
228
206
185
288
372
0
0
0
0
0
0
0
0
22,006
16,984
7,989
0
0
35,863
35,863007,98916,98422,00600000000372288185206228250680291311000000
       Deferred Long Term Liability 
0
0
0
0
1,481
0
9
91
895
250
228
206
185
288
372
0
0
295
0
2,959
0
0
0
22,006
16,984
7,989
0
0
0
0007,98916,98422,0060002,95902950037228818520622825089591901,4810000
> Total Stockholder Equity
16,420
15,126
8,248
-358
32,001
0
7,297
-38,900
14,881
-51,856
144,788
133,658
284,317
269,637
246,256
220,489
181,467
149,115
281,020
253,101
225,753
196,937
166,528
380,947
351,689
322,263
284,151
235,769
195,628
195,628235,769284,151322,263351,689380,947166,528196,937225,753253,101281,020149,115181,467220,489246,256269,637284,317133,658144,788-51,85614,881-38,9007,297032,001-3588,24815,12616,420
   Common Stock
3
53
53
93
10
0
10
93
10
2
27
27
34
34
34
34
34
35
44
44
44
44
44
50
50
50
50
50
50
5050505050504444444444353434343434272721093100109353533
   Retained Earnings Total Equity-626,704-581,703-528,939-486,073-450,966-415,577-459,327-424,430-390,612-359,495-325,331-292,375-256,372-213,576-184,602-159,095-141,123-126,711-110,252-99,721000000000
   Accumulated Other Comprehensive Income 
0
-46
-55
0
0
0
-144
0
-252
0
-367
-367
0
0
-809
-809
0
0
-752
-752
1,000
0
49
-58
21
21
-1
-629
-906
-906-629-12121-584901,000-752-75200-809-80900-367-3670-2520-144000-55-460
   Capital Surplus 
0
0
0
0
0
0
0
0
0
47,784
255,013
260,342
425,406
428,698
430,824
434,031
437,805
441,455
606,307
612,552
615,691
621,085
625,762
796,532
802,584
808,265
813,041
818,051
823,188
823,188818,051813,041808,265802,584796,532625,762621,085615,691612,552606,307441,455437,805434,031430,824428,698425,406260,342255,01347,784000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
630
621,323
625,762
796,532
802,584
808,265
813,041
818,051
823,188
823,188818,051813,041808,265802,584796,532625,762621,32363000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue3,154
Cost of Revenue-599
Gross Profit2,5552,555
 
Operating Income (+$)
Gross Profit2,555
Operating Expense-172,614
Operating Income-170,059-170,059
 
Operating Expense (+$)
Research Development104,128
Selling General Administrative68,486
Selling And Marketing Expenses-
Operating Expense172,614172,614
 
Net Interest Income (+$)
Interest Income447
Interest Expense--
Net Interest Income447447
 
Pretax Income (+$)
Operating Income-170,059
Net Interest Income447
Other Non-Operating Income Expenses100,447
Income Before Tax (EBT)-69,612-270,506
EBIT - interestExpense = -69,612
-69,612
-69,612
Interest Expense-
Earnings Before Interest and Taxes (ebit)-69,612-69,612
Earnings Before Interest and Taxes (ebitda)-68,454
 
After tax Income (+$)
Income Before Tax-69,612
Tax Provision-0
Net Income From Continuing Ops-69,612-69,612
Net Income-69,612
Net Income Applicable To Common Shares-69,612
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses173,213
Total Other Income/Expenses Net100,447-100,894
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
5 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
5 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
5 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
5 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
5 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
5 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
5 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
5 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart